Mailis Gagnon is member of the Advisory Board for Lyrica (Pfizer Canada) and Cymbalta (Eli LillyCanada) and has received a research grant from Pfizer Canada (2009), an unrestricted educational grant from Purdue Pharma, Valeant Canada Ltd and Paladin Labs (2010) and honoraria for talks (Pfizer Canada, Eli Lilly Canada). She is also advisor to Elafi Digital Media Inc., a company owned by her husband.